Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-007384
Filing Date
2025-03-07
Accepted
2025-03-07 16:08:55
Documents
1
Period of Report
2025-03-05

Document Format Files

Seq Description Document Type Size
1 form4-03072025_090351.html 4  
1 form4-03072025_090351.xml 4 3627
  Complete submission text file 0001415889-25-007384.txt   5044
Mailing Address 45 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 45 SIDNEY STREET CAMBRIDGE MA 02139 617-374-7580
Blueprint Medicines Corp (Issuer) CIK: 0001597264 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address BLUEPRINT MEDICINES CORPORATION 38 SIDNEY STREET, SUITE 200 CAMBRIDGE MA 02139
Business Address
Haviland Kate (Reporting) CIK: 0001663022 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37359 | Film No.: 25720119